Drug discovery pact between Charles River and Valo Health nets potential ... covered by the wide-ranging partnership is to address unmet needs within Pfizer’s core strategic areas of interest.

Pfizer and Flagship will engage Charles River Laboratories to leverage Logica, an artificial intelligence (AI)-powered platform offering from Flagship-founded Valo Health ... “Through the power of our ...

Collaboration leverages Logica, a platform offering from Valo Health and Charles ... signed under strategic partnership between Flagship Pioneering and Pfizer to accelerate discovery of ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic diseases, leveraging AI and extensive human datasets.

Valo Health, Inc. (“Valo”), a biotechnology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence (AI), today ...

Novo Nordisk gets a license to three preclinical-stage cardiovascular disease programmes from Valo Health in return for its initial investment and is prepared to expand the partnership to cover 11 ...

Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday ... Under the initial partnership signed in 2023, the duo agreed to jointly advance up ...